Smith & Nephew SNATS (NYSE:SNN) Stock Gets Downgrade from Wall Street Zen

Smith & Nephew SNATS (NYSE:SNN) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

SNN has been the topic of several other research reports. Bank of America lowered Smith & Nephew SNATS from a “buy” rating to a “neutral” rating in a report on Tuesday, September 8th. JPMorgan Chase & Co. lowered Smith & Nephew SNATS from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 6th. Morgan Stanley lowered Smith & Nephew SNATS from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, September 2nd. Zacks Research raised shares of Smith & Nephew SNATS from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 8th. Finally, Weiss Ratings cut shares of Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, September 24th. One equities research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $31.91.

Smith & Nephew SNATS Trading Down 2.7%

Shares of SNN stock opened at $31.16 on Friday. Smith & Nephew SNATS has a 12-month low of $26.12 and a 12-month high of $37.09. The firm has a fifty day moving average of $28.50 and a 200-day moving average of $31.05. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11.

Institutional Trading of Smith & Nephew SNATS

A number of institutional investors and hedge funds have recently bought and sold shares of SNN. BlackRock Inc. purchased a new stake in shares of Smith & Nephew SNATS during the second quarter valued at $505,323,000. Bank of America Corp DE purchased a new stake in Smith & Nephew SNATS during the second quarter worth approximately $97,223,000. Bank of New York Mellon Corp acquired a new stake in Smith & Nephew SNATS in the second quarter worth $89,325,000. Caisse de depot et placement du Quebec acquired a new stake in Smith & Nephew SNATS during the 2nd quarter worth about $64,186,000. Finally, Legal & General Group Plc bought a new position in Smith & Nephew SNATS during the second quarter worth $35,338,000. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company that develops and manufactures products used by healthcare professionals to treat injuries, manage wounds and restore patients’ mobility. Founded in 1856 by Thomas James Smith in Hull, England, the company has grown from a pharmacy business into an international healthcare manufacturer.

The company operates across three principal areas: orthopaedics, sports medicine and ear, nose and throat (ENT), and advanced wound management.